Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dayvigo
Pharma
Idorsia requests to de-schedule DORA insomnia drugs
Idorsia has sent a petition to the DEA trying to get its insomnia treatment Quvivq off the Schedule IV controlled substance list.
Kevin Dunleavy
Apr 7, 2023 10:55am
Idorsia taps actor Taye Diggs to pitch new insomnia drug Quviviq
May 27, 2022 8:15am
Idorsia's insomnia drug Quviviq hits the market
May 9, 2022 10:15am
Idorsia wins its first FDA approval with insomnia drug Quviviq
Jan 10, 2022 7:57am